Pharmaceutical

KB-707 by Krystal Biotech for Solid Tumor: Likelihood of Approval

KB-707 is under clinical development by Krystal Biotech and currently in Phase I for Solid Tumor.

Dec 26, 2023 - 18:00
KB-707 is under clinical development by Krystal Biotech and currently in Phase I for Solid Tumor.
Read the original article

Tags:

Previous Article

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

Next Article

ORB-011 by Orionis Biosciences for Head And Neck Squamous Cell Carcinoma (HNSC):...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Three lessons from Covid that could help global leaders prevent the next pandemic

Three lessons from Covid that could help global leaders...

Sep 6, 2023

Takeda’s ADZYNMA gains EU approval for cTTP treatment

Takeda’s ADZYNMA gains EU approval for cTTP treatment

Aug 9, 2024

NCCN visits Vietnam in continued cancer care collaboration

NCCN visits Vietnam in continued cancer care collaboration

Nov 3, 2024